Phase I/II Clinical Trial of 26-valent Pneumococcal Conjugate Vaccine

Clinical trial NCT06703203 · COMPLETED

Trial details

NCT number: NCT06703203
Sponsor: Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2025-07-17
Primary completion: 2025-08-05
Enrollment: 450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.